Pathology and AI: Page 2

EnsoData’s AI-powered sleep study diagnostic gets FDA 510(k) clearance
By LabPulse.com staff writers
EnsoData has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its machine learning-based diagnostic for sleep apnea and other sleep disorders that uses data from pulse oximetry devices.
February 26, 2024
Fda Button Social
Proscia receives 510(k) clearance from FDA for digital pathology solution
By Matt Limb
Software company Proscia has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its digital pathology solution, Concentriq AP-Dx.
February 12, 2024
Fda Sign Dc Social
Opentrons Labworks unveils AI-powered workflow tools
By Matt Limb
Lab automation and robotics firm Opentrons Labworks Inc has unveiled new tools intended to enhance the efficiency of research across genomics, proteomics, cell biology, and synthetic biology.
February 8, 2024
Artificial Intelligence Ai Hand Social
Hologic receives FDA clearance for digital cytology scanner platform in U.S.
By Liz Carey
Acknowledging human papillomavirus (HPV) as a causative agent for cervical cancer, the new system is designed to complement molecular testing for HPV with cotesting for cervical cancer.
February 2, 2024
Genius Review Station Social
BD, Techcyte team for AI-enabled digital cervical cytology system
By LabPulse.com staff writers
Becton Dickinson (BD) and Techcyte have announced a strategic collaboration agreement designed to, in time, add artificial intelligence (AI) to cervical cancer screening in the U.S.
January 30, 2024
Business Handshake Intelligence Social
FDA accepts 1st AI-based tool into Istand pilot program
By LabPulse.com staff writers
A mental health assessment tool has become the first AI-powered tool to be accepted into the U.S. Food and Drug Administration's (FDA) Innovative Science and Technology Approaches for New Drugs (Istand) pilot program for advancing drug development.
January 26, 2024
Computer Brain Hemisphere Social
Genetic-informed model improves prediction of blood cancer prognosis
By Nick Paul Taylor
Researchers have used genetic, treatment, and clinical data to improve prediction of the prognosis of patients with multiple myeloma.
January 18, 2024
Multiple Myeloma Social
Imvaria gets FDA marketing authorization for Fibresolve
By AuntMinnie.com staff writers
The U.S. Food and Drug Administration (FDA) has cleared Imvaria for the use of Fibresolve.
January 16, 2024
Lungs 3 D Research 400
Gestalt adds Sagis Diagnostics for digital pathology and AI
By LabPulse.com staff writers
Texas-based pathology group to implement digital pathology with AI using Gestalt platform.
January 11, 2024
Pathology Digital Workstation Microscope Social
Algorithm for drug repurposing unveiled at NeurIPS
By LabPulse.com staff writers
A team at Klick Applied Sciences have created an artificial intelligence (AI) framework that can identify new indications for existing drugs.
January 2, 2024
Pharmaceutical Artificial Intelligence Social
Owkin and MSD to collaborate on cancer diagnostics
By LabPulse.com staff writers
Biotech firm Owkin has formed a collaboration with MSD (Merck) to develop and commercialize AI-powered digital microsatellite instability high (MSI-H) pathology cancer diagnostics for EU markets.
December 19, 2023
Business Handshake Man Social
U.K. researchers use deep learning to develop rapid antimicrobial resistance test
By Matt Limb
Researchers are hailing progress toward more rapid detection of antimicrobial resistance (AMR), with a susceptibility test returning results in 30 minutes.
December 1, 2023
Antibiotic Resistant Bacteria Social
Previous Page
Page 2 of 176
Next Page